George Nicholas B, Baldassari Jashua Haddad, Pérez Taveras Digno A, José Fernández María, Concepción Robledo María
Department of Medicine, School of Health Sciences, Pontificia Universidad Católica Madre y Maestra, Santiago, Republica Dominicana.
Diagn Cytopathol. 2017 Jun;45(6):520-525. doi: 10.1002/dc.23707. Epub 2017 Mar 24.
Atypical squamous cells of undetermined significance (ASCUS) and atypical glandular cells (AGC) reflect cellular abnormalities insufficient for clear diagnosis. We used cell pellets obtained from liquid-based cytology (LBC) to prepare cell blocks (CB) and clarify the initial diagnosis of ASCUS and AGC.
A total of 393 CBs with initial diagnosis of ASCUS or AGC were processed. Of those, 305 of the ASCUS and 20 of the AGC had adequate specimens. We compared results of CBs prepared from ASCUS and AGC to determine which had higher frequencies of higher-grade lesions.
A majority of specimens (83%) were adequate for evaluation. Compared with the initial diagnosis, 14% (42/305) of ASCUS were diagnosed with low-grade squamous intraepithelial lesion (LSIL) in CB, while 10% (2/20) of AGC were diagnosed with LSIL or adenocarcinoma. No statistical relationship between the initial diagnosis of ASCUS and AGC and results of higher-grade lesions in CB is evident as determined by p value greater than 0.05 (p = 0.228).
CBs prepared from Liqui-PREP cell pellets are, in most cases, assessable and can be useful as an adjunctive test to help clarify the initial diagnosis of ASCUS and AGC. Diagn. Cytopathol. 2017;45:520-525. © 2017 Wiley Periodicals, Inc.
意义不明确的非典型鳞状细胞(ASCUS)和非典型腺细胞(AGC)反映了细胞异常情况,但不足以做出明确诊断。我们使用从液基细胞学(LBC)获得的细胞团块制备细胞块(CB),以明确ASCUS和AGC的初步诊断。
对总共393个初步诊断为ASCUS或AGC的细胞块进行处理。其中,305个ASCUS和20个AGC有足够的标本。我们比较了从ASCUS和AGC制备的细胞块的结果,以确定哪些细胞块中高级别病变的频率更高。
大多数标本(83%)足以进行评估。与初步诊断相比,在细胞块中,14%(42/305)的ASCUS被诊断为低级别鳞状上皮内病变(LSIL),而10%(2/20)的AGC被诊断为LSIL或腺癌。通过p值大于0.05(p = 0.228)确定,ASCUS和AGC的初步诊断与细胞块中高级别病变的结果之间没有明显的统计学关系。
从Liqui-PREP细胞团块制备的细胞块在大多数情况下是可评估的,并且可以作为辅助检测手段,有助于明确ASCUS和AGC的初步诊断。诊断细胞病理学。2017;45:520 - 525。©2017威利期刊公司。